M. Davis

发表

Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS)

F. Farraye, M. Yenikomshian, L. Huynh, 2016, Journal of medical economics.

Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.

D. Rubin, M. Skup, J. Chao, 2017, Journal of managed care & specialty pharmacy.

Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance

Songkai Yan, G. Krishnarajah, B. Haider, 2016, Human vaccines & immunotherapeutics.

Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors

D. Rubin, M. Skup, J. Chao, 2017, Current medical research and opinion.

Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs*

H. Birnbaum, P. Cremieux, J. Ivanova, 2009, Current medical research and opinion.

CEOR_A_303079 251..261

G. R. Williams, A. Epstein, D. Mehta, 2021 .

Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population

A. Fendrick, D. Rubin, P. Mease, 2019, Patient preference and adherence.

Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy

A. Fendrick, P. Mease, M. Mittal, 2023, Advances in Therapy.

Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.

A. Fendrick, D. Rubin, P. Mease, 2021, Journal of managed care & specialty pharmacy.

Impact of Online Prescription Management Systems on Biologic Treatment Initiation

D. Brixner, M. Mittal, J. Hawkes, 2019, Advances in Therapy.

Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.

A. Fendrick, D. Rubin, P. Mease, 2019, Journal of managed care & specialty pharmacy.

Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis

M. Duh, S. Sarda, M. Fay, 2015, Journal of medical economics.

A Cost Comparison of Split-Dose Reduced-Volume oral Sulfate Solution (OSS) And Polyethylene Glycol With Electrolytes Solution (Peg-Els)

F. Farraye, M. Yenikomshian, L. Huynh, 2015 .

Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.

H. Birnbaum, P. Cremieux, J. Ivanova, 2009, Current medical research and opinion.

Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs

G. R. Williams, A. Epstein, D. Mehta, 2021, ClinicoEconomics and outcomes research : CEOR.

Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD

G. R. Williams, A. Epstein, D. Mehta, 2021, Journal of medical economics.

The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US

H. Birnbaum, J. Ivanova, A. Phillips, 2012, PharmacoEconomics.

Impact of Formulary Restrictions on Antiepileptic Drug Dispensation Outcomes

A. Epstein, D. Mehta, M. Davis, 2020, Neurology and Therapy.

Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses

G. R. Williams, A. Epstein, D. Mehta, 2020, Neurology and Therapy.

Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice

G. R. Williams, A. Epstein, D. Mehta, 2020, ClinicoEconomics and outcomes research : CEOR.

Early retirement and income loss in patients with early and advanced Parkinson’s disease

H. Birnbaum, A. Siderowf, Scott J Johnson, 2011, Applied health economics and health policy.

Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors

D. Rubin, M. Skup, J. Chao, 2017, Current medical research and opinion.

Early retirement and income loss in patients with early and advanced Parkinson’s disease

H. Birnbaum, A. Siderowf, Scott J Johnson, 2011, Applied health economics and health policy.